Effets indésirables neuropsychiatriques des fluoroquinolones : Un risque méconnuCHIFFOLEAU, Anne; NOWOCZYN, Marie; JACOB, Carine et al.Concours médical (Paris). 2008, Vol 130, Num 1, pp 31-33, issn 0010-5309, 3 p.Article

Effect of N-1/C-8 Ring Fusion and C-7 Ring Structure on Fluoroquinolone LethalityMALIK, Muhammad; MARKS, Kevin R; SCHWANZ, Heidi A et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 12, pp 5214-5221, issn 0066-4804, 8 p.Article

Challenges in Assessing Microbial Susceptibility and Predicting Clinical Response to Newer-Generation FluoroquinolonesSEGRETI, John; JONES, Ronald N; BERTINO, Joseph S et al.Journal of ocular pharmacology and therapeutics. 2012, Vol 28, Num 1, pp 3-11, issn 1080-7683, 9 p.Article

Fluoroquinolone prophylaxis in patients with neutropenia : a meta-analysis of randomized placebo-controlled trialsIMRAN, H; TLEYJEH, I. M; ARNDT, C. A. S et al.European journal of clinical microbiology & infectious diseases (Print). 2008, Vol 27, Num 1, pp 53-63, issn 0934-9723, 11 p.Article

Fluoroquinolone Efflux in Streptococcus suis Is Mediated by SatAB and Not by SmrAESCUDERO, Jose Antonio; MILLAN, Alvaro San; GONZALEZ-ZORN, Bruno et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 12, pp 5850-5860, issn 0066-4804, 11 p.Article

In Vitro Antibacterial Activities of JNJ-Q2, a New Broad-Spectrum FluoroquinoloneMORROW, Brian J; WENPING HE; AMSLER, Karen M et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 5, pp 1955-1964, issn 0066-4804, 10 p.Article

Human Organic Cation Transporters 1 (SLC22A1), 2 (SLC22A2), and 3 (SLC22A3) as Disposition Pathways for Fluoroquinolone AntimicrobialsMULGAONKAR, Aditi; VENITZ, Jürgen; GRÜNDEMANN, Dirk et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 6, pp 2705-2711, issn 0066-4804, 7 p.Article

Penetration of Moxifloxacin into Bone Evaluated by Monte Carlo SimulationLANDERSDORFER, Cornelia B; KINZIG, Martina; HENNIG, Friedrich F et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 5, pp 2074-2081, issn 0066-4804, 8 p.Article

SatR Is a Repressor of Fluoroquinolone Efflux Pump SatABESCUDERO, Jose Antonio; SAN MILLAN, Alvaro; MONTERO, Natalia et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 7, pp 3430-3433, issn 0066-4804, 4 p.Article

The Effect of Moxifloxacin on QTc and Implications for the Design of Thorough QT StudiesBLOOMFIELD, D. M; KOST, J. T; GHOSH, K et al.Clinical pharmacology and therapeutics. 2008, Vol 84, Num 4, pp 475-480, issn 0009-9236, 6 p.Article

En bref ― Fluoroquinolones et neuropathie périphérique = In brief: fluoroquinolones and peripheral neuropathyThe Medical letter on drugs and therapeutics (Edition française). 2013, Vol 35, Num 25, issn 0253-8512, p. 101Article

In Vitro Susceptibility Testing of Fluoroquinolone Activity Against Salmonella: Recent Changes to CLSI StandardsHUMPHRIES, Romney M; FANG, Ferric C; AARESTRUP, Frank M et al.Clinical infectious diseases. 2012, Vol 55, Num 8, pp 1107-1113, issn 1058-4838, 7 p.Article

Novel Mechanism for Fluoroquinolone Resistance in Acinetobacter baumanniiSAROJ, Sunil D; CLEMMER, Katy M; BONOMO, Robert A et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 9, pp 4955-4957, issn 0066-4804, 3 p.Article

Synthesis and antibacterial activity of new fluoroquinolones containing a cis- or trans-cyclohexane moietyQI, Qing-Rong; JIAPAN; GUO, Xiao-Qiang et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 24, pp 7688-7692, issn 0960-894X, 5 p.Article

Can phylogenetic type predict resistance development?NAZIR, Humera; SHA CAO; HASAN, Fariha et al.Journal of antimicrobial chemotherapy (Print). 2011, Vol 66, Num 4, pp 778-787, issn 0305-7453, 10 p.Article

Antipneumococcal Activity of Ulifloxacin Compared to Levofloxacin and CiprofloxacinPALLECCHI, L; RICCOBONO, E; MONTAGNANI, F et al.Journal of chemotherapy (Testo stampato). 2011, Vol 23, Num 5, pp 308-309, issn 1120-009X, 2 p.Article

Effect of Emergence of Fluoroquinolone Resistance on Intrinsic Expression of P-Glycoprotein Phenotype in Corneal Epithelial CellsBAROT, Megha; GOKULGANDHI, Mitan R; HAGHNEGAHDAR, Megan et al.Journal of ocular pharmacology and therapeutics. 2011, Vol 27, Num 6, pp 553-559, issn 1080-7683, 7 p.Article

Impact of recA on Levofloxacin Exposure-Related Resistance DevelopmentSINGH, Renu; LEDESMA, Kimberly R; CHANG, Kai-Tai et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 10, pp 4262-4268, issn 0066-4804, 7 p.Article

In Vitro Activities of DC-159a, a Novel Fluoroquinolone, against Mycobacterium SpeciesDISRATTHAKIT, Areeya; DOI, Norio.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 6, pp 2684-2686, issn 0066-4804, 3 p.Article

Emergence of Fluoroquinolone Resistance in Group B Streptococcal Isolates in TaiwanWU, Hsiu-Mei; PRASAD JANAPATLA, Rajendra; HO, Yueh-Ren et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 5, pp 1888-1890, issn 0066-4804, 3 p.Article

Antibacterial activity of moxifloxacin on bacteria associated with periodontitis within a biofilmTSAOUSOGLOU, Phoebus; NIETZSCHE, Sandor; CACHOVAN, Georg et al.Journal of medical microbiology. 2014, Vol 63, Num 2, pp 284-292, issn 0022-2615, 9 p.Article

Risk of hepatotoxicity associated with fluoroquinolones: A national case―control safety studyALSHAMMARI, Thamir M; LARRAT, E. Paul; MORRILL, Haley J et al.American journal of health-system pharmacy. 2014, Vol 71, Num 1, pp 37-43, issn 1079-2082, 7 p.Article

Effects of ciprofloxacin on the expression and production of exotoxins by Clostridium difficileALDAPE, Michael John; PACKHAM, Aaron Eugene; NUTE, Drew William et al.Journal of medical microbiology. 2013, Vol 62, Num 5, pp 741-747, issn 0022-2615, 7 p.Article

Rhumatologie : Enrichir et mettre à jour à jour sa panoplie pour mieux soigner, le tri 2012 = Rheumatology : 2012 updateLa Revue Prescrire. 2013, Vol 33, Num 351, issn 0247-7750, p. 58Article

Prospective Clinical Evaluation of 1.5% Levofloxacin Ophthalmic Solution in Ophthalmic Perioperative DisinfectionSUZUKI, Takashi; TANAKA, Hiroshi; TORIYAMA, Koji et al.Journal of ocular pharmacology and therapeutics. 2013, Vol 29, Num 10, pp 887-892, issn 1080-7683, 6 p.Article